Overview software 960px

Bruker Mass Spectrometry Webinars

Moving Beyond the Boundaries in Early Drug Discovery

Division of Pharmacy Professional Development

Success or failure in drug development starts during the early stages of drug discovery. In this series of webinars, conducted together with the Division of Pharmacy Professional Development at the University of Wisconsin, we will discuss today's challenges, opportunities and state-of-the-art technologies in early drug discovery.

In the first installment of the series, W. Adam Hill will give an insight into the challenges and limitations researchers are facing in early drug discovery. Following this, Matthias Trost shows how the drug discovery process can be accelerated beyond conventional technologies with advanced mass spectrometry technology. In the third webinar of the series, Melanie Leveridge will discuss how the MALDI-TOF works in a real life pharmaceutical application.

We invite you to join this webinar series to stay up to date on recent advancements in early drug discovery workflows.

For abstracts and information about the presenters, click here.

Please use the respective links to register for the webinars:

Wednesday, 24 May, 2017

12:00 pm to 1:00 pm CDT

Changes and Challenges in Early Drug Discovery Today

Presenter: W. Adam Hill, CEO, Prospective
Research Inc., Beverly, MA

register now

Wednesday, 31 May, 2017

12:00 pm to 1:00 pm CDT

High-throughput MALDI TOF Mass Spectrometry for Drug Discovery in the Ubiquitin System

Presenter: Matthias Trost, Professor of Proteomics, Newcastle University, Newscastle-upon-Tyne, UK and Program Leader and Head of Proteomics at the MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Scotland

register now

Wednesday, 7 June, 2017

12:00 pm to 1:00 pm CDT

Advancements in MALDI-TOF Mass Spectrometry towards Ultra High Throughput Screening

Presenter: Melanie Leveridge, Head Screening Profiling and Mechanistic Biology, GlaxoSmithKline, Stevenage, UK

register now